mdlinx mdlinx

Pharmacy News & Articles

MDLinx Pharmacy helps physicians and healthcare professionals stay up to date with the latest pharmacy news articles and research, as well as pharmacy jobs, conferences, and resources.

Your Unread Messages in Pharmacy

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Articles

Latest (58) Full Text Articles (1329)
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

1 Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol Full Text JACC - Journal of the American College of Cardiology, October 8, 2012 Original Publication Date: October 7, 2011    Clinical Article

2 New data from ORIGIN Shows Lantus use is about 3 times more likely to achieve and sustain target HbA1c vs. standard care over 5 years in the study population Full Text Sanofi-aventis, October 8, 2012

3 The cytochrome P450 inhibitor, ketoconazole, inhibits oxidized linoleic acid metabolite-mediated peripheral inflammatory pain Full Text Molecular Pain, October 8, 2012

4 A Phase I Dose Esclation Study of Tivantinib in Adult Pts w Metastatic Solid Tumors Full Text Clinical Cancer Research, October 8, 2012 Original Publication Date: October 7, 2011    Clinical Article

5 Costs of Illness Due to Cholera, Costs of Immunization and Cost-Effectiveness of an Oral Cholera Mass Vaccination Campaign in Zanzibar Full Text PLoS Neglected Tropical Diseases, October 8, 2012    Clinical Article

6 Multicenter, Phase II Study of Axitinib, a Selective Second-Generation Inhibitor of Vascular Endothelial Growth Factor Receptors 1, 2, 3, in Patients with Metastatic Melanoma Full Text Clinical Cancer Research, October 8, 2012 Original Publication Date: October 7, 2011    Clinical Article

7 Phase I/II and Pharmacodynamic Study of Dovitinib (TKI258)-an Inhibitor of Fibroblast Growth Factor Receptors and VEGF Receptors-in Patients with Advanced Melanoma Full Text Clinical Cancer Research, October 8, 2012 Original Publication Date: October 7, 2011    Clinical Article

8 A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors Full Text Investigational New Drugs, October 8, 2012    Clinical Article

9 Phase I and pharmacokinetic study of pazopanib and lapatinib combination therapy in patients with advanced solid tumors Full Text Investigational New Drugs, October 8, 2012    Clinical Article

10 GPhA Receives Favorable Opinion on Shortage Initiative Full Text U.S. Pharmacist, October 8, 2012

11 Outcome Comparison of 600- and 300-mg Loading Doses of Clopidogrel in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Full Text JACC - Journal of the American College of Cardiology, October 7, 2012 Original Publication Date: October 6, 2011    Clinical Article

12 Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial Full Text Annals of Oncology, October 7, 2012 Original Publication Date: October 6, 2011    Clinical Article

13 Impact of the Everolimus-Eluting Stent on Stent Thrombosis: A Meta-Analysis of 13 Randomized Trials Full Text JACC - Journal of the American College of Cardiology, October 7, 2012 Original Publication Date: October 7, 2011    Evidence Based Medicine    Clinical Article

14 Randomized front line trial utilizing tumor genomic profiling tests OPAXIO plus radiation therapy compared to current standard of care of radiation with temozolamide in high risk patients with glioblastoma multiforme Full Text Cell Therapeutics, October 5, 2012

15 In vitro Characterization of the Oxidation of a Pyridinium Metabolite of Haloperidol by Human Placenta: The Effect of Smoking Full Text Journal of Pharmacy and Pharmaceutical Sciences, October 5, 2012

16 Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy Full Text BMC Neurology, October 5, 2012

17 Introduction to the use of belatacept: a fusion protein for the prevention of posttransplant kidney rejection Full Text Biologics: targets & therapy, October 5, 2012    Clinical Article

18 Dopamine Receptor Blockade Attenuates the General Incentive Motivational Effects of Noncontingently Delivered Rewards and Reward-Paired Cues Without Affecting Their Ability to Bias Action Selection Full Text Neuropsychopharmacology, October 5, 2012 Original Publication Date: October 4, 2011

19 Shionogi-ViiV Healthcare announces completion of initial clinical registration package for dolutegravir in HIV Full Text GlaxoSmithKline, October 5, 2012

20 Distinct Contributions of Dopamine in the Dorsolateral Striatum and Nucleus Accumbens Shell to the Reinforcing Properties of Cocaine Full Text Neuropsychopharmacology, October 5, 2012 Original Publication Date: October 4, 2011

67 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Pharmacy Articles

Last month's top read Top Articles of 2012

Indexed Journals in Pharmacy: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacistmore

Other Topics in Pharmacy

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close